DIARRHEA RELIEF LIQUID GELS 2 MG
LOPERAMIDE HYDROCHLORIDE : 2 MG · DIN 02553139 · ANGITA PHARMA INC.
Health Canada status: MARKETED
What is DIARRHEA RELIEF LIQUID GELS?
DIARRHEA RELIEF LIQUID GELS 2 MG contains LOPERAMIDE HYDROCHLORIDE : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02553139, held by ANGITA PHARMA INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 25-Aug-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02553139 |
|---|---|
| Brand name | DIARRHEA RELIEF LIQUID GELS |
| Generic / active ingredient | LOPERAMIDE HYDROCHLORIDE : 2 MG |
| Manufacturer | ANGITA PHARMA INC. |
| Strength | 2 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07DA03 LOPERAMIDE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-Aug-2025 |
What can be used instead?
Other Canadian products sharing ATC code A07DA03 LOPERAMIDE. 14 of 39 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DIARRHEA RELIEF | 2 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02256452 |
| DIARRHEA RELIEF | 2 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02248994 |
| DIARRHEA RELIEF FAST DISSOLVE | 2 MG | TABLET (ORALLY DISINTEGRATING) | JUNO OTC INC | MARKETED | DIN 02499517 |
| DIARRHEA RELIEF LIQUID GELS | 2 MG | CAPSULE | LABORATOIRE RIVA INC. | MARKETED | DIN 02552337 |
| IMODIUM CALMING LIQUID | 2 MG / 15 ML | SOLUTION | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02291800 |
| IMODIUM LIQUI-GELS | 2 MG | CAPSULE | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02376016 |
| IMODIUM QUICK DISSOLVE | 2 MG | TABLET (ORALLY DISINTEGRATING) | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02230542 |
| JAMP LOPERAMIDE | 2 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02544989 |
| LOPERAMIDE-2 | 2 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02225182 |
| PMS-LOPERAMIDE - CAPLET 2MG | 2 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02228351 |
Who else supplies LOPERAMIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LOPERAMIDE appears in 37 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.